Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality
BiotechReality – Information Intelligence System for Biopharma
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #Clinical Data #Cancer #FDA Approval #Novo Nordisk #Pfizer

Tag: Bacteria

Research Vaccines

New Vaccination Concept Targets Dangerous Bacteria in the Intestine

  • By Ajmal Aseem
  • 4 April 2025
new vaccination concept

For a long time, scientists have been looking into vaccines against pathogenic bacteria in the bowel, particularly those that drugs have proved ineffective against due to resistance.

Tagged Bacteria, Vaccination
Microbiology Research

Memories are passed down to offspring by bacterial cells

  • By Editor's Desk
  • 30 August 2024
antibiotic resistant bacteria

It is like the communication network that genes have among them to affect one another.

Tagged Bacteria
Healthcare & Pharmaceuticals News

Environmental Bacteria Could Form Better Antibiotics

  • By Journal Updates
  • 16 August 2024
Caulobacter

Results showed that the deletion of a protein, OpgH, in a model bacterium, Caulobacter crescentus, sets off an event cascade that ultimately splits apart the protective, bubble-like cell envelope, eventually killing the cell.

Tagged Antibiotics, Bacteria
Research

Discovery of bacteria that can destroy Forever Chemicals

  • By Editor's Desk
  • 20 July 2024
antibiotic resistant bacteria

Per- and polyfluoroalkyl substances, or PFAS, are another name for forever chemicals. These compounds persist in the environment because of their strong carbon-fluorine chemical interactions.

Tagged Bacteria, Forever Chemicals
Diseases Research

Gut bacteria can cause inherited eye diseases which lead to blindness

  • By Journal Updates
  • 1 March 2024
COAST phase 3 clinical trial

A recent study in mice co-led by a researcher from Moorfields and UCL suggests that gut bacteria may be the cause of sight loss in certain hereditary eye illnesses, and that antimicrobials may be able to cure the condition.

Tagged Bacteria, Blindness, Eyes
Microbiology News

Researchers discovered the bacteria’s mechanism for recognition of viral invasion and immune activation

  • By Editor's Desk
  • 23 November 2023
phage attack
Researchers discovered the bacteria's mechanism for recognition of viral invasion and immune activation

Researchers at The Rockefeller University have discovered that bacteria sense phages via a defensive response called CBASS that detects viral RNA

Tagged Bacteria, Virus
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

Novartis Fabhalta Iptacopan FDA Approval Becomes First Complement Inhibitor to Slow Kidney Decline in Primary IgAN
Regulatory Approval Healthcare & Pharmaceuticals News

Novartis Fabhalta Iptacopan FDA Approval Becomes First Complement Inhibitor to Slow Kidney Decline in Primary IgAN

18 July 202617 July 2026
Regulatory Intelligence Desk
LIPFENDRA FDA Approval: Merck’s Enlicitide Becomes First Oral PCSK9 Inhibitor to Lower LDL-C
Regulatory Approval Healthcare & Pharmaceuticals News

LIPFENDRA FDA Approval: Merck’s Enlicitide Becomes First Oral PCSK9 Inhibitor to Lower LDL-C

17 July 202617 July 2026
Regulatory Intelligence Desk
GSK Nuvalent Acquisition: GSK Completes $10.6 Billion Nuvalent Acquisition, Expanding Lung Cancer Pipeline
Merger & Acquisitions Business Healthcare & Pharmaceuticals

GSK Nuvalent Acquisition: GSK Completes $10.6 Billion Nuvalent Acquisition, Expanding Lung Cancer Pipeline

16 July 202616 July 2026
BiotechReality Business Intelligence Desk
Johnson & Johnson Q2 2026 Analysis: Company Reports $25.3 Billion in Sales, Raises Full-Year Outlook
Business Healthcare & Pharmaceuticals News

Johnson & Johnson Q2 2026 Analysis: Company Reports $25.3 Billion in Sales, Raises Full-Year Outlook

15 July 202616 July 2026
BiotechReality Business Intelligence Desk
Merck’s Erbitux BRAF V600E mCRC Regimen Gets EU Approval for First-Line Treatment
Regulatory Approval Healthcare & Pharmaceuticals News Oncology

Merck’s Erbitux BRAF V600E mCRC Regimen Gets EU Approval for First-Line Treatment

15 July 202615 July 2026
Regulatory Intelligence Desk
AstraZeneca Zegfrovy Deal: AstraZeneca Licenses Dizal’s Oral EGFR Inhibitor for Lung Cancer in Up to $1.5 Billion Agreement
Merger & Acquisitions Healthcare & Pharmaceuticals News Oncology

AstraZeneca Zegfrovy Deal: AstraZeneca Licenses Dizal’s Oral EGFR Inhibitor for Lung Cancer in Up to $1.5 Billion Agreement

14 July 202615 July 2026
BiotechReality Business Intelligence Desk
Advertisement
BiotechReality JobFinder

  • Quality Specialist – Thermo Fisher Scientific
    17 July 2026
  • HSE Specialist – Novartis
    17 July 2026
  • Field Application Specialist – Sartorius
    14 July 2026
  • Regulatory Professional – Novo Nordisk
    12 July 2026
  • Senior Biotechnologist – Sanofi
    10 July 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter